Salix Pharmaceuticals - Advancing Treatment in Gastroenterology

Governance and Compliance

At Salix, we realize that operating with transparency develops and fosters trust with our stockholders, partners, and the patients who benefit from our products. Download the following documents to learn more about our governance and compliance policies.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX: VRX) completed its acquisition of Salix Pharmaceuticals, Ltd. ("Salix") on April 1, 2015.

Read the latest Investor Relations information from Valeant

Consumer Product Safety Improvement Act (CPSIA)

View the certifications for Salix products sold in child-resistant packaging as required by the Consumer Product Safety Improvement Act 2008

Salix Sharps Collection & Disposal Plan

Salix Sharps Collection & Disposal Plan

Check out our latest Press Releases and News